Prevalences and associated risk factors of HCV/HIV co-infection and HCV mono-infection among injecting drug users in a methadone maintenance treatment program in Taipei, Taiwan

被引：0
|
作者：
Yung-Feng Yen
Muh-Yong Yen
Lien-Wen Su
Lan-Huei Li
Peing Chuang
Xiao-Ru Jiang
Chung-Yeh Deng
机构：
[1] Taipei City Hospital,Section of Infectious Diseases
[2] Taipei City Government,Department of Disease Control and Prevention
[3] Taipei City Hospital,Division of Mental Health and Addiction Medicine
[4] Taipei City Government,Institute of Hospital and Health Care Administration
[5] Taipei City Hospital,Institute of Public Health
[6] Taipei City Government,undefined
[7] National Yang-Ming University,undefined
[8] National Yang-Ming University,undefined
来源：
BMC Public Health | / 12卷
关键词：
HCV; HIV; Taiwan; Injection drug use; Methadone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Prevalences and associated risk factors of HCV/HIV co-infection and HCV mono-infection among injecting drug users in a methadone maintenance treatment program in Taipei, Taiwan
    Yen, Yung-Feng
    Yen, Muh-Yong
    Su, Lien-Wen
    Li, Lan-Huei
    Chuang, Peing
    Jiang, Xiao-Ru
    Deng, Chung-Yeh
    [J]. BMC PUBLIC HEALTH, 2012, 12
  • [2] HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination
    Leyna, Germana Henry
    Makyao, Neema
    Mwijage, Alexander
    Ramadhan, Angela
    Likindikoki, Samuel
    Mizinduko, Mucho
    Leshabari, Melkizedeck Thomas
    Moen, Kare
    Mmbaga, Elia John
    [J]. HARM REDUCTION JOURNAL, 2019, 16 (01)
  • [3] HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination
    Germana Henry Leyna
    Neema Makyao
    Alexander Mwijage
    Angela Ramadhan
    Samuel Likindikoki
    Mucho Mizinduko
    Melkizedeck Thomas Leshabari
    Kåre Moen
    Elia John Mmbaga
    [J]. Harm Reduction Journal, 16
  • [4] HIV and HCV infection among injecting drug users
    Hagan, H
    Jarlais, DCD
    [J]. MOUNT SINAI JOURNAL OF MEDICINE, 2000, 67 (5-6): : 423 - 428
  • [5] High Prevalence of HIV, HCV, HBV and Co-Infection and Associated Risk Factors among Injecting Drug Users in Yunnan Province, China
    Zhou, Yan-Heng
    Yao, Zhi-Hong
    Liu, Feng-Liang
    Li, Hong
    Jiang, Li
    Zhu, Jia-Wu
    Zheng, Yong-Tang
    [J]. PLOS ONE, 2012, 7 (08):
  • [6] HIV Infection Risk among Injection Drug Users in a Methadone Maintenance Treatment Program, Taipei, Taiwan 2007-2010
    Yen, Yung-Feng
    Rodwell, Timothy C.
    Yen, Muh-Yong
    Hsu, Yun-Hsia
    Chuang, Peing
    Li, Lan-Huei
    Su, Lien-Wen
    Yang, Yi-Hong
    Jiang, Xiao-Ru
    Fang, Yung-Chun
    Garfein, Richard S.
    [J]. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2012, 38 (06): : 544 - 550
  • [7] Mitochondrial Abnormalities in Patients with HIV-HCV Co-infection as Compared to Patients with HCV Mono-infection
    Chapplain, Jean-Marc
    Tattevin, Pierre
    Guyader, Dominique
    Begue, Jean-Marc
    Beillot, Jocelyne
    Turlin, Bruno
    Souala, Faouzi
    Arvieux, Cedric
    Rochcongar, Pierre
    Michelet, Christian
    [J]. HIV CLINICAL TRIALS, 2011, 12 (01): : 54 - 60
  • [8] Hepatic giant cells in hepatitis C virus (HCV) mono-infection and HCV/HIV co-infection
    Micchelli, S. T. L.
    Thomas, D.
    Boitnott, J. K.
    Torbenson, M.
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2008, 61 (09) : 1058 - 1061
  • [9] Markers of liver fibrosis and apoptosis in patients with HIV mono-infection and HIV/HCV co-infection
    Viksna, Ludmila
    Eksteina, Ilze
    Madelane, Monta
    Zeltina, Indra
    Krumina, Angelika
    Kolesovs, Aleksandrs
    Simanis, Raimonds
    [J]. HIV & AIDS REVIEW, 2019, 18 (01): : 33 - 39
  • [10] Body composition and metabolic alterations in chronic hepatitis C (HCV) mono-infection and HIV/HCV co-infection
    Kaplounov, I
    Engelson, E
    Reka, S
    Kotler, D
    [J]. GASTROENTEROLOGY, 2004, 126 (04) : A745 - A745
12345